Duquesne Family Office – NEKTAR THERAPEUTICS

Duquesne Family Office ownership history of NEKTAR THERAPEUTICS
QuarterValueSharesWeighting
Q2 2021$17,160
-14.2%
1,000,0000.0%0.49%
-4.3%
Q1 2021$20,000
198.3%
1,000,000
222.0%
0.52%
161.4%
Q4 2019$6,704
-94.7%
310,579
-74.0%
0.20%
-97.2%
Q1 2018$126,694
15.7%
1,192,300
-35.0%
7.00%
26.8%
Q4 2017$109,526
291.4%
1,834,000
57.3%
5.52%
333.7%
Q3 2017$27,986
22.8%
1,166,1000.0%1.27%
4.3%
Q2 2017$22,797
45.9%
1,166,100
75.2%
1.22%
19.1%
Q1 2017$15,622
58.9%
665,600
16.3%
1.02%
18.0%
Q3 2016$9,829
36.4%
572,100
-12.7%
0.87%
-5.1%
Q1 2015$7,205
-29.0%
655,0000.0%0.92%
-7.9%
Q4 2014$10,153655,0001.00%